Literature DB >> 20836021

Systems approaches and algorithms for discovery of combinatorial therapies.

Jacob D Feala1, Jorge Cortes2, Phillip M Duxbury3, Carlo Piermarocchi3, Andrew D McCulloch4, Giovanni Paternostro1.   

Abstract

Effective therapy of complex diseases requires control of highly nonlinear complex networks that remain incompletely characterized. In particular, drug intervention can be seen as control of cellular network activity. Identification of control parameters presents an extreme challenge due to the combinatorial explosion of control possibilities in combination therapy and to the incomplete knowledge of the systems biology of cells. In this review paper, we describe the main current and proposed approaches to the design of combinatorial therapies, including the heuristic methods used now by clinicians and alternative approaches suggested recently by several authors. New approaches for designing combinations arising from systems biology are described. We discuss in special detail the design of algorithms that identify optimal control parameters in cellular networks based on a quantitative characterization of control landscapes, maximizing utilization of incomplete knowledge of the state and structure of intracellular networks. The use of new technology for high-throughput measurements is key to these new approaches to combination therapy and essential for the characterization of control landscapes and implementation of the algorithms. Combinatorial optimization in medical therapy is also compared with the combinatorial optimization of engineering and materials science and similarities and differences are delineated.

Mesh:

Year:  2010        PMID: 20836021     DOI: 10.1002/wsbm.51

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Syst Biol Med        ISSN: 1939-005X


  46 in total

1.  Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.

Authors:  Brian J Park; Zakary L Whichard; Seth J Corey
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

2.  Optimization of drug combinations using Feedback System Control.

Authors:  Patrycja Nowak-Sliwinska; Andrea Weiss; Xianting Ding; Paul J Dyson; Hubert van den Bergh; Arjan W Griffioen; Chih-Ming Ho
Journal:  Nat Protoc       Date:  2016-01-14       Impact factor: 13.491

3.  A scalable method for molecular network reconstruction identifies properties of targets and mutations in acute myeloid leukemia.

Authors:  Edison Ong; Anthony Szedlak; Yunyi Kang; Peyton Smith; Nicholas Smith; Madison McBride; Darren Finlay; Kristiina Vuori; James Mason; Edward D Ball; Carlo Piermarocchi; Giovanni Paternostro
Journal:  J Comput Biol       Date:  2015-04       Impact factor: 1.479

4.  Combinatorial therapy discovery using mixed integer linear programming.

Authors:  Kaifang Pang; Ying-Wooi Wan; William T Choi; Lawrence A Donehower; Jingchun Sun; Dhruv Pant; Zhandong Liu
Journal:  Bioinformatics       Date:  2014-01-24       Impact factor: 6.937

5.  Prediction of multidimensional drug dose responses based on measurements of drug pairs.

Authors:  Anat Zimmer; Itay Katzir; Erez Dekel; Avraham E Mayo; Uri Alon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-25       Impact factor: 11.205

6.  Anticancer drug synergy prediction in understudied tissues using transfer learning.

Authors:  Yejin Kim; Shuyu Zheng; Jing Tang; Wenjin Jim Zheng; Zhao Li; Xiaoqian Jiang
Journal:  J Am Med Inform Assoc       Date:  2021-01-15       Impact factor: 4.497

Review 7.  Modeling Tumor Clonal Evolution for Drug Combinations Design.

Authors:  Boyang Zhao; Michael T Hemann; Douglas A Lauffenburger
Journal:  Trends Cancer       Date:  2016-03

8.  Statistical metamodeling for revealing synergistic antimicrobial interactions.

Authors:  Hsiang Chia Chen; Chia Hsiang Chen; Vincent Gau; Donna D Zhang; Joseph C Liao; Fei-Yue Wang; Pak Kin Wong
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

9.  Directed neural differentiation of induced pluripotent stem cells from non-human primates.

Authors:  Steven L Farnsworth; Zhifang Qiu; Anuja Mishra; Peter J Hornsby
Journal:  Exp Biol Med (Maywood)       Date:  2013-03

10.  TIde: a software for the systematic scanning of drug targets in kinetic network models.

Authors:  Marvin Schulz; Barbara M Bakker; Edda Klipp
Journal:  BMC Bioinformatics       Date:  2009-10-19       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.